| Dr Douglas Mark Nadel, MD | |
|
599 W State St Ste 201, The Pavilion At Doylestown Hospital, Doylestown, PA 18901 | |
| (215) 345-5323 | |
| (215) 345-5329 |
| Full Name | Dr Douglas Mark Nadel |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 32 Years |
| Location | 599 W State St Ste 201, Doylestown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407875503 | NPI | - | NPPES |
| 0016601780005 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MD053927L (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Doylestown Hospital | Doylestown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pinnacle Ent Alliance Llc | 7416963988 | 39 |
News Archive
CANCER RESEARCH UK's Centre for Drug Development, in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, today (TUESDAY) announce a new trial at The Royal Marsden and University College London that could revolutionise how children with one of the deadliest forms of cancer are diagnosed.
A new study examines fertility issues in male and female childhood cancer survivors who had received chemotherapy. The study found that while most female survivors still have a good chance of conceiving, male survivors are significantly less likely to father children.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.
The 4D scans of 15 healthy fetuses, by Durham and Lancaster Universities, also suggest that yawning is a developmental process which could potentially give doctors another index of a fetus' health.
› Verified 4 days ago
| Entity Name | Pinnacle Ent Alliance Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538230313 PECOS PAC ID: 7416963988 Enrollment ID: O20060222000064 |
News Archive
CANCER RESEARCH UK's Centre for Drug Development, in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, today (TUESDAY) announce a new trial at The Royal Marsden and University College London that could revolutionise how children with one of the deadliest forms of cancer are diagnosed.
A new study examines fertility issues in male and female childhood cancer survivors who had received chemotherapy. The study found that while most female survivors still have a good chance of conceiving, male survivors are significantly less likely to father children.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.
The 4D scans of 15 healthy fetuses, by Durham and Lancaster Universities, also suggest that yawning is a developmental process which could potentially give doctors another index of a fetus' health.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Douglas Mark Nadel, MD 599 W State St Ste 201, The Pavilion At Doylestown Hospital, Doylestown, PA 18901-2567 Ph: (215) 345-5323 | Dr Douglas Mark Nadel, MD 599 W State St Ste 201, The Pavilion At Doylestown Hospital, Doylestown, PA 18901 Ph: (215) 345-5323 |
News Archive
CANCER RESEARCH UK's Centre for Drug Development, in collaboration with the Rising Tide Foundation, a Swiss-based non-profit organisation which funds innovative cancer trials, today (TUESDAY) announce a new trial at The Royal Marsden and University College London that could revolutionise how children with one of the deadliest forms of cancer are diagnosed.
A new study examines fertility issues in male and female childhood cancer survivors who had received chemotherapy. The study found that while most female survivors still have a good chance of conceiving, male survivors are significantly less likely to father children.
Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the presentation of recent preclinical data using its next generation of minimally invasive intradermal (skin) electroporation delivery devices at the Phacilitate Vaccine Forum 2011 in Washington, DC.
The 4D scans of 15 healthy fetuses, by Durham and Lancaster Universities, also suggest that yawning is a developmental process which could potentially give doctors another index of a fetus' health.
› Verified 4 days ago
Dr. Brent R Rosen, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3655 Route 202, Suite 225-230, Doylestown, PA 18902 Phone: 215-230-4013 Fax: 215-230-4143 | |
Dr. Marc Aaron Stiefel, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 599 W State St, Suite 201, Doylestown, PA 18901 Phone: 215-345-5323 Fax: 215-345-5329 |